Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Julia Brosch-Lenz"'
Autor:
Francesca De Benetti, Julia Brosch-Lenz, Jorge Mario Guerra González, Carlos Uribe, Matthias Eiber, Nassir Navab, Thomas Wendler
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-16 (2024)
Abstract Background Dosimetry-based personalized therapy was shown to have clinical benefits e.g. in liver selective internal radiation therapy (SIRT). Yet, there is no consensus about its introduction into clinical practice, mainly as Monte Carlo si
Externí odkaz:
https://doaj.org/article/db75b97f01194d1d8ff6a20f240410cd
Autor:
Adrian Jun Zounek, Nathalie Lisa Albert, Adrien Holzgreve, Marcus Unterrainer, Julia Brosch-Lenz, Simon Lindner, Andreas Bollenbacher, Guido Boening, Rainer Rupprecht, Matthias Brendel, Louisa von Baumgarten, Joerg-Christian Tonn, Peter Bartenstein, Sibylle Ziegler, Lena Kaiser
Publikováno v:
Zeitschrift für Medizinische Physik, Vol 33, Iss 1, Pp 91-102 (2023)
Introduction: Large datasets are required to ensure reliable non-invasive glioma assessment with radiomics-based machine learning methods. This can often only be achieved by pooling images from different centers. Moreover, trained models should perfo
Externí odkaz:
https://doaj.org/article/a511eca412ca469481eb848eddd5a508
Autor:
Pia M. Linder, Wenhong Lan, Nils F. Trautwein, Julia Brosch-Lenz, Sebastian von Beschwitz, Jürgen Kupferschläger, Gerald Reischl, Gerd Grözinger, Helmut Dittmann, Christian la Fougère, Fabian P. Schmidt
Publikováno v:
Diagnostics, Vol 13, Iss 22, p 3418 (2023)
Background: PET imaging after yttrium-90 (Y-90) radioembolization is challenging because of the low positron fraction of Y-90 (32 × 10−6). The resulting low number of events can be compensated by the high sensitivity of long axial field-of-view (L
Externí odkaz:
https://doaj.org/article/6b0a73105f26449a845a235dfe0d17ca
Autor:
Arman Rahmim, Julia Brosch-Lenz, Ali Fele-Paranj, Fereshteh Yousefirizi, Madjid Soltani, Carlos Uribe, Babak Saboury
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
This work emphasizes that patient data, including images, are not operable (clinically), but that digital twins are. Based on the former, the latter can be created. Subsequently, virtual clinical operations can be performed towards selection of optim
Externí odkaz:
https://doaj.org/article/2efee901f8de45f2a05d5a5d691a8392
Autor:
Julia Brosch-Lenz, Carlos Uribe, Astrid Gosewisch, Lena Kaiser, Andrei Todica, Harun Ilhan, Franz Josef Gildehaus, Peter Bartenstein, Arman Rahmim, Anna Celler, Sibylle Ziegler, Guido Böning
Publikováno v:
EJNMMI Physics, Vol 8, Iss 1, Pp 1-17 (2021)
Abstract Background Patients with metastatic, castration-resistant prostate cancer (mCRPC) present with an increased tumor burden in the skeleton. For these patients, Lutetium-177 (Lu-177) radioligand therapy targeting the prostate-specific membrane
Externí odkaz:
https://doaj.org/article/c9fccf5729724045b8a9ec1cb9928c5d
Autor:
Julia Brosch-Lenz, Carlos Uribe, Astrid Gosewisch, Lena Kaiser, Andrei Todica, Harun Ilhan, Franz Josef Gildehaus, Peter Bartenstein, Arman Rahmim, Anna Celler, Sibylle Ziegler, Guido Böning
Publikováno v:
EJNMMI Physics, Vol 8, Iss 1, Pp 1-2 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/9e8827c4a4214aa48c10f9de6e2531a6
Autor:
Lena Kaiser, Adrien Holzgreve, Stefanie Quach, Michael Ingrisch, Marcus Unterrainer, Franziska J. Dekorsy, Simon Lindner, Viktoria Ruf, Julia Brosch-Lenz, Astrid Delker, Guido Böning, Bogdana Suchorska, Maximilian Niyazi, Christian H. Wetzel, Markus J. Riemenschneider, Sophia Stöcklein, Matthias Brendel, Rainer Rupprecht, Niklas Thon, Louisa von Baumgarten, Jörg-Christian Tonn, Peter Bartenstein, Sibylle Ziegler, Nathalie L. Albert
Publikováno v:
Cancers, Vol 14, Iss 1, p 53 (2021)
In this study, dual PET and contrast enhanced MRI were combined to investigate their correlation per voxel in patients at initial diagnosis with suspected glioblastoma. Correlation with contrast enhancement (CE) as an indicator of BBB leakage was fur
Externí odkaz:
https://doaj.org/article/69d0391fdb524e3fba906c1fc2459008
Autor:
Friederike Völter, Lena Mittlmeier, Astrid Gosewisch, Julia Brosch-Lenz, Franz Josef Gildehaus, Mathias Johannes Zacherl, Leonie Beyer, Christian G. Stief, Adrien Holzgreve, Johannes Rübenthaler, Clemens C. Cyran, Guido Böning, Peter Bartenstein, Andrei Todica, Harun Ilhan
Publikováno v:
Diagnostics, Vol 11, Iss 3, p 428 (2021)
Background: Dosimetry can tailor prostate-specific membrane-antigen-targeted radioligand therapy (PSMA-RLT) for metastatic castration-resistant prostate cancer (mCRPC). However, whole-body tumor dosimetry is challenging in patients with a high tumor
Externí odkaz:
https://doaj.org/article/9465067559e145b7ba908c6f40a7d0fb
Autor:
Julia Brosch-Lenz, Astrid Delker, Friederike Völter, Lena M. Unterrainer, Lena Kaiser, Peter Bartenstein, Sibylle Ziegler, Arman Rahmim, Carlos Uribe, Guido Böning
Publikováno v:
Journal of Nuclear Medicine. 64:767-774
Autor:
Astrid Gosewisch, Julia Brosch-Lenz
Publikováno v:
Der Nuklearmediziner. 44:355-368
ZusammenfassungDie Peptid-Radiorezeptor-Therapie (PRRT) mit Lutetium-177 (177Lu) hat sich als vielversprechende Therapieoption von metastasierten neuroendokrinen Tumoren (NETs) etabliert. Des Weiteren wird die Yttrium-90 (90Y) selektive interne Radio